Scilex (SCLX) Competitors $18.05 -0.19 (-1.01%) As of 10:13 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SCLX vs. MNMD, SANA, KURA, NBTX, NAGE, SEPN, OCS, IOVA, VIR, and GHRSShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include Mind Medicine (MindMed) (MNMD), Sana Biotechnology (SANA), Kura Oncology (KURA), Nanobiotix (NBTX), Niagen Bioscience (NAGE), Septerna (SEPN), Oculis (OCS), Iovance Biotherapeutics (IOVA), Vir Biotechnology (VIR), and GH Research (GHRS). These companies are all part of the "pharmaceutical products" industry. Scilex vs. Its Competitors Mind Medicine (MindMed) Sana Biotechnology Kura Oncology Nanobiotix Niagen Bioscience Septerna Oculis Iovance Biotherapeutics Vir Biotechnology GH Research Scilex (NASDAQ:SCLX) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings. Do analysts rate SCLX or MNMD? Scilex presently has a consensus target price of $455.00, indicating a potential upside of 2,421.47%. Mind Medicine (MindMed) has a consensus target price of $26.50, indicating a potential upside of 118.38%. Given Scilex's higher probable upside, analysts clearly believe Scilex is more favorable than Mind Medicine (MindMed).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scilex 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20Mind Medicine (MindMed) 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00 Is SCLX or MNMD more profitable? Mind Medicine (MindMed) has a net margin of 0.00% compared to Scilex's net margin of -179.12%. Scilex's return on equity of 0.00% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Scilex-179.12% N/A -109.95% Mind Medicine (MindMed) N/A -50.24%-39.41% Which has higher valuation and earnings, SCLX or MNMD? Scilex has higher revenue and earnings than Mind Medicine (MindMed). Mind Medicine (MindMed) is trading at a lower price-to-earnings ratio than Scilex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScilex$56.59M2.22-$72.81M-$29.02-0.62Mind Medicine (MindMed)N/AN/A-$108.68M-$1.53-7.93 Does the media refer more to SCLX or MNMD? In the previous week, Scilex had 1 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 2 mentions for Scilex and 1 mentions for Mind Medicine (MindMed). Scilex's average media sentiment score of 0.91 beat Mind Medicine (MindMed)'s score of 0.65 indicating that Scilex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Scilex 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mind Medicine (MindMed) 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, SCLX or MNMD? Scilex has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.55, suggesting that its share price is 155% more volatile than the S&P 500. Do institutionals and insiders have more ownership in SCLX or MNMD? 69.7% of Scilex shares are held by institutional investors. Comparatively, 27.9% of Mind Medicine (MindMed) shares are held by institutional investors. 7.9% of Scilex shares are held by company insiders. Comparatively, 2.3% of Mind Medicine (MindMed) shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryScilex beats Mind Medicine (MindMed) on 9 of the 16 factors compared between the two stocks. Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLX vs. The Competition Export to ExcelMetricScilexMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$122.46M$3.37B$6.14B$10.60BDividend YieldN/A2.29%5.70%4.74%P/E Ratio-0.6121.5885.6726.93Price / Sales2.22468.20621.78136.94Price / CashN/A47.6737.7861.77Price / Book-0.6510.0713.116.70Net Income-$72.81M-$52.22M$3.30B$276.44M7 Day Performance-12.74%4.94%4.37%2.94%1 Month Performance-18.61%13.14%9.02%9.40%1 Year Performance-38.58%27.38%86.98%35.23% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXScilex2.2118 of 5 stars$18.05-1.0%$455.00+2,421.5%-43.1%$122.46M$56.59M-0.6180MNMDMind Medicine (MindMed)2.3287 of 5 stars$12.04+12.8%$26.50+120.1%+128.0%$811.86MN/A-7.8740Gap UpHigh Trading VolumeSANASana Biotechnology3.2223 of 5 stars$3.54+6.0%$7.50+111.9%-2.1%$794.27MN/A-3.34380Positive NewsKURAKura Oncology3.998 of 5 stars$8.97-0.9%$24.10+168.7%-47.3%$785.52M$53.88M-3.97130NBTXNanobiotix1.2629 of 5 stars$18.02+11.0%$11.00-39.0%+310.4%$778.60M$39.18M0.00100Analyst RevisionGap UpHigh Trading VolumeNAGENiagen Bioscience2.9298 of 5 stars$9.90+1.4%$13.42+35.6%N/A$778.39M$99.60M47.15120Analyst RevisionSEPNSepterna1.6307 of 5 stars$18.15+4.0%$26.75+47.4%N/A$778.01M$1.08M-1.80N/AOCSOculis2.8195 of 5 stars$17.54-0.5%$35.75+103.8%+33.5%$769.77M$780K-6.572News CoverageAnalyst ForecastGap UpIOVAIovance Biotherapeutics4.5024 of 5 stars$2.23+5.7%$11.90+433.6%-78.2%$763.51M$164.07M-1.81500VIRVir Biotechnology3.649 of 5 stars$5.63+2.6%$17.30+207.3%-23.5%$762.65M$74.21M-1.41580News CoverageInsider TradeGHRSGH Research2.089 of 5 stars$14.53+0.6%$32.00+120.2%+107.8%$751.29MN/A-19.6310 Related Companies and Tools Related Companies MNMD Alternatives SANA Alternatives KURA Alternatives NBTX Alternatives NAGE Alternatives SEPN Alternatives OCS Alternatives IOVA Alternatives VIR Alternatives GHRS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCLX) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
